Inspiration Healthcare Group PLC CFM unit granted CE mark and Neotech Agreement.
January 18 2018 - 2:00AM
RNS Non-Regulatory
TIDMIHC
Inspiration Healthcare Group PLC
18 January 2018
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
New Generation Wireless Brain Monitoring CFM unit granted CE
mark
and renewal of Neotech distribution agreement.
Inspiration Healthcare Group plc (AIM: IHC), the global medical
device company, is delighted to announce that its new generation
CFM (Cerebral Function Monitor)
unit, the Unique+, designed for use in neonatal applications has
been granted a CE mark*. The product will be released for sale in
the UK starting in February 2018, followed swiftly by major
European markets and other key territories in the world as the
product becomes registered with the respective regulatory
bodies.
The Cerebral Function Monitoring is designed to monitor the
electrical activity in the brain of neonatal infants and has been a
key component of Inspiration Healthcare's product offering since
2004. The new Unique+ is the next generation of CFM offered by
Inspiration with the further refinement of both hardware and
software elements, and the addition of smart features to improve
connectivity and the user experience, including:
-- A combined amplifier and headbox in one battery powered,
lightweight unit and modern user interface
-- Simple identification of electrode placement with LED-lit
connection points for single channel and dual channel monitoring,
and
-- Connectivity via USB, Bluetooth and now the additional option
of WiFi enabling remote connectivity to PCs or hospital computer
networks
The Unique+ is state-of-the-art and can be introduced into
previously untapped markets including North America and Russia.
At the same time, the Company is pleased to announce that it has
renewed a distribution contract with Neotech Products LLC, the US
specialist manufacture of products used in neonatal intensive care
applications and has agreed a further two year term. In the current
year, the Company estimates the total revenues from the sale of
Neotech products in the UK will amount to in excess of GBP0.1m.
Commenting today, Neil Campbell Inspiration Healthcare's Chief
Executive Officer said: "The Unique+ CFM re-affirms Inspiration
Healthcare's commitment to improving diagnostic and treatment of
the newborn brain. It also shows our commitment to investing in new
technology and developing our product portfolio that will allow us
to penetrate further into key international markets. We are also
delighted to extend our relationship with Neotech and continuing as
the UK distributors for their medical devices."
* CE marking is a mandatory conformity marking for certain
products sold within the European Economic Area (EEA).
Enquiries:
Inspiration Healthcare Tel: 01455 840555
Group plc
Neil Campbell, Chief
Executive Officer
Mike Briant, Chief Financial
Officer
------------------------------ -------------------
Nominated Adviser & Tel: 0207 397 8900
Broker
Cenkos Securities plc
Bobbie Hilliam / Mark
Connelly
------------------------------ -------------------
Cadogan PR Tel: 07771 713608
Alex Walters
------------------------------ -------------------
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global supplier of
medical technology for critical care, operating theatre and other
medical applications. The Company provides high quality innovative
products to patients and caregivers around the world that help to
improve patient outcomes and efficiencies of healthcare
organisations with patient focused customer service and technical
support.
The Company's own brand of critical care solutions span
non-invasive respiratory management, thermoregulation and
diagnostics, and patient warming for newborns through to adults in
intensive care and the operating theatre, whilst the distribution
business supplies solutions to support specialised surgical
procedures and infusion therapies.
Present in over 50 countries worldwide, Inspiration Healthcare's
success has been built on continuous innovation, excellent customer
service and an inherent commitment to improving the quality of life
of patients, working in close collaboration with key opinion
leaders and stakeholders in the clinical and medical community
across the globe.
Further information on Inspiration Healthcare can be seen at
www.inspiration-healthcare.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRADDLFFVFFXBBK
(END) Dow Jones Newswires
January 18, 2018 02:00 ET (07:00 GMT)
Inspiration Healthcare (LSE:IHC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Inspiration Healthcare (LSE:IHC)
Historical Stock Chart
From Apr 2023 to Apr 2024